Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.

Jensen, Anders Boisen et al.·Obesity surgery·2023·
RPEP-070042023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.
Published In:
Obesity surgery, 33(4), 1017-1025 (2023)
Database ID:
RPEP-07004

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-07004·https://rethinkpeptides.com/research/RPEP-07004

APA

Jensen, Anders Boisen; Renström, Frida; Aczél, Stefan; Folie, Patrick; Biraima-Steinemann, Magdalena; Beuschlein, Felix; Bilz, Stefan. (2023). Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.. Obesity surgery, 33(4), 1017-1025. https://doi.org/10.1007/s11695-023-06484-8

MLA

Jensen, Anders Boisen, et al. "Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.." Obesity surgery, 2023. https://doi.org/10.1007/s11695-023-06484-8

RethinkPeptides

RethinkPeptides Research Database. "Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Li..." RPEP-07004. Retrieved from https://rethinkpeptides.com/research/jensen-2023-efficacy-of-the-glucagonlike

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.